Exploring antimicrobial properties of cholesterol esters: a systematic literature review

References

• Arendrup MC. 2013. Update on antifungal resistance in Aspergillus and Candida. Clin Microbiol Infect. 20(6):42–48. doi:10.1111/1469-0691.12513.
   Google Scholar
• Chastre J. 2008. Evolving problems with resistant pathogens. Clin Microbiol Infec. 14(3):3–14. doi:10.1111/j.1469-0691.2008.01958.x.
   PubMedGoogle Scholar
• Desbois AP, Smith VJ. 2010. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol. 85(6):1629–1642. doi:10.1007/s00253-009-2355-3.
   PubMed Web of Science ®Google Scholar
• Do TQ, Moshkani S, Castillo P, Anunta S, Pogosyan A, Cheung A, Marbois B, Faull KM, Ernst W, Chiang SM, et al. 2008. Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid. J Immunol. 181(6):4177–4187. doi:10.4049/jimmunol.181.6.4177.
   PubMed Web of Science ®Google Scholar
• Drake DR, Brogden KA, Dawson DV, Wertz PW. 2008. Thematic review series: skin lipids. antimicrobial lipids at the skin surface. J Lipids Res. 49:4–11.
   PubMed Web of Science ®Google Scholar
• Durieu I, Abbas-Chorfa F, Drai J, Iwaz J, Steghens JP, Puget M, Ecochard R, Bellon G. 2007. Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis. Eur Respir J. 29(5):958–964. doi:10.1183/09031936.00000906.
   PubMed Web of Science ®Google Scholar
• Fischer CL. 2020. Antimicrobial activity of host-derived lipids. Antibiotics. 9:75.
   Google Scholar
• Fischer CL, Drake DR, Dawson DV, Blanchette DR, Brogden KA, Wertz PW. 2012. Antibacterial activity of sphingoid bases and fatty acids against gram-positive and gram-negative bacteria. Antimicrob Agents Chemother. 56:1157–1161. doi:10.1128/aac.05151-11].
   PubMed Web of Science ®Google Scholar
• Georgel P, Crozat K, Lauth X, Makrantonaki E, Seltmann H, Sovath S, Hoebe K, Du X, Rutschmann S, Jiang Z, et al. 2005. A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria. Infect Immun. 73(8):4512–4521. doi:10.1128/IAI.73.8.4512-4521.2005.
   PubMed Web of Science ®Google Scholar
• Hurt AC, Chotpitatasunondh T, Cox NJ, Daniels R, Fry AM, Gubareva LV, Hayden FG, Hui DS, Hungnes O, Lackenby A, et al. 2012. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Infect Dis. 12(3):240–248. doi:10.1016/S1473-3099(11)70318-8.
   Web of Science ®Google Scholar
• Jansen MA, Kiwata J, Arceo J, Faull KF, Hanrahan G, Porter E. 2010. Evolving neural network optimisation of cholesteryl ester separation by reversed-phase HPLC. Anal Bioanal Chem. 397(6):2367–2374.
   PubMed Web of Science ®Google Scholar
• Johnson AP. 2015. Surveillance of antibiotic resistance. Philos Trans R Soc Lond B Biol Sci. 370(1670):20140080. doi:10.1098/rstb.2014.0080.
   PubMed Web of Science ®Google Scholar
• Kiwata J, Anouseyan R, Desharnais R, Cornwell A, Khoudiguian N, Porter E. 2014. Effects of aerobic exercise on lipid-effector molecules of the innate immune response. Med Sci Sport Exer. 46(3):506–512.
   PubMed Web of Science ®Google Scholar
• Kiwata J, Anoyseyan R, Cornwell A, Khoudiguian N, Porter E. 2011. The effect of vigorous exercise on antimicrobial effector molecule content in upper respiratory tract secretions. Med Sci Sports Exerc. 43(5):337. doi:10.1249/01.MSS.0000400930.35055.39.
   Web of Science ®Google Scholar
• Krogfelt KA, Utley M, Krivan HC, Laux DC, Cohen PS. 2000. Specific phospholipids enhance the activity of beta-lactam antibiotics against Pseudomonas aeruginosa. J Antimicrob Chemother. 46:377–384. doi:10.1093/jac/46.3.377.
   PubMed Web of Science ®Google Scholar
• Lam AHC, Sandoval N, Wadhwa R, Gilkes J, Do TQ, Ernst W, Su-Ming C, Kosina S, Xu HH, Fuiji G, Porter E. 2016. Assessment of free fatty acids and cholesteryl esters delivered in liposomes as novel class of antibiotic. BMC Res Notes. 9:337. doi:10.1186/s13104-016-2138-8.
   PubMedGoogle Scholar
• Lee JT, Escobar OH, Anouseyan R, Janisiewicz A, Eivers E, Blackwell KE, Keschner DB, Garg R, Porter E. 2014. Assessment of epithelial innate antimicrobial factors in sinus tissue from patients with and without chronic rhinosinusitis. Allergy Rhinol. 4(11):893–900. doi:10.1002/alr.21404.
   Web of Science ®Google Scholar
• Lee JT, Jansen M, Yilma AN, Nguyen A, Desharnais R, Porter E. 2010. Antimicrobial lipids: novel innate defense molecules are elevated in sinus secretions of patients with chronic rhinosinusitis. Am J Rhinol Allergy. 24(2):99–104. doi:10.2500/ajra.2010.24.3444.
   PubMed Web of Science ®Google Scholar
• Li TCM, Chan MCW, Lee N. 2015. Clinical implications of antiviral resistance in influenza. Viruses. 4929–4944. doi:10.3390/v7092850.
   PubMed Web of Science ®Google Scholar
• Lim YS. 2017. Management of antiviral resistance in chronic hepatitis B. Gut Liver. 11(2):189–195. doi:10.5009/gnl15562.
   PubMed Web of Science ®Google Scholar
• Ma DC, Yoon AJ, Faull KF, Desharnais R, Zemanick ET, Porter E. 2015. Cholesteryl esters are elevated in the lipid fraction of bronchoalveolar lavage fluid collected from pediatric cystic fibrosis patients. PLoS One. 10(4). doi:10.1371/journal.pone.0125326.
   Web of Science ®Google Scholar
• Mitchell KF, Taff HT, Cuevas MA, Reinicke EL, Sanchez H, Andes DR. 2013. Role of matrix B-1,3 glucan in antifungal resistance of non-albicans candida biofilms. Antimicrobiol Agents Chemother. 57(4):1918–1920. doi:10.1128/AAC.02378-12.
   PubMed Web of Science ®Google Scholar
• Mudgil P. 2014. Antimicrobial role of human meibomian lipids at the ocular surface. Invest Ophthalmol Vis Sci. 55:7272–7277.
   PubMed Web of Science ®Google Scholar
• Pani A, Norfo C, Abete C, Mulas C, Putzolu M, Laconi S, Orru CD, Cannas MD, Vascellari S, La Colla P, Dessi S. 2007. Antiprion activity of cholesterol esterification modulators: A comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines. Antiviral Agents. 51(11). doi:10.1128/AAC.00524-07.
   Google Scholar
• Porter E, Ma DC, Alvarez S, Faull KF. 2015. Antimicrobial lipids: emerging effector molecules of innate host defense. World J Immunol. 5(2):51–61.
   Google Scholar
• Posokhova EN, Khoshchenko OM, Chasovskikh MI, Pivovarova EN, Dushkin MI. 2008. Lipid synthesis in macrophages during inflammation in vivo: effect of agonists of peroxisome proliferator activated receptors α and γ and of retinoid X receptors. Biochem. 73:296–304.
   PubMed Web of Science ®Google Scholar
• Wertz PW, de Szalay S. 2020. Innate antimicrobial defense of skin and oral mucosa. Antibiotics. 9:159. doi:10.3390/antibiotics9040159.
   Google Scholar
• Zhang Q, Wu W, Zhang J, Xia X. 2020. Antimicrobial lipids in nano-carriers for antimicrobial delivery. J Drug Target. 28(3):271–281. doi:10.1080/1061186X.2019.1681434.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhang M, Yang W, Fang Y, Wang G, Hou F. 2016. A seventeen-year observation of the antimicrobial susceptibility of clinical Campylobacter jejuni and the molecular mechanisms of erythromycin-resistant isolates in Beijing, China. Int J Infect Dis. 42:28–33. doi:10.1016/j.ijid.2015.11.005.
   PubMed Web of Science ®Google Scholar